Join to View Full Profile
225 E Chicago AveChicago, IL 60611
Phone+1 312-227-4090
Dr. Sokol is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elizabeth Sokol is a Pediatric Hematologist and Oncologist based in Chicago, IL. She graduated from the University of Illinois College of Medicine in 2011 and completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at the University of Chicago. Dr. Sokol has expertise in neuroblastoma and has authored several publications on topics related to pediatric oncology, including induction chemotherapy in high-risk neuroblastoma, AI-based classification of neuroblastic tumors, and clinical practice guidelines for neuroblastoma. Her work has been cited in other scientific publications, reflecting her contributions to the field.
Education & Training
University of ChicagoFellowship, Pediatric Hematology/Oncology, 2014 - 2017- University of ChicagoResidency, Pediatrics, 2011 - 2014
University of Illinois College of MedicineClass of 2011
Certifications & Licensure
IL State Medical License 2014 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- A Rare Answer to a Common Presentation: Gastric Neoplasm in a Teenager With Vomiting.Jonathan Lebowitz, Ariel Porto, Christine Nguyen Clarke, Elizabeth Sokol, John E Fortunato
The Journal of Adolescent Health. 2024-12-01 - Response to induction chemotherapy modifies the effect of conventional prognostic factors in high-risk neuroblastoma: A report from the Children's Oncology Group.Elizabeth Sokol, Brian LaBarre, Navin Pinto, Susan Kreissman, M Meaghan Granger
EJC Paediatric Oncology. 2024-12-01 - Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.Siddhi Ramesh, Emma Dyer, Monica Pomaville, Kristina Doytcheva, James Dolezal
NPJ Precision Oncology. 2024-11-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
